Literature DB >> 17046320

Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis.

Guy Boivin1, Nathalie Goyette, Yan Sergerie, Sharon Keays, Tristan Booth.   

Abstract

BACKGROUND: Few studies have performed sequential evaluation of the herpes simplex virus (HSV) load using quantitative PCR during episodes of herpes labialis.
OBJECTIVE: To determine HSV viral load kinetics during recurrences of herpes labialis. STUDY
DESIGN: Twenty-two subjects were monitored by daily swabs during recurrences of herpes labialis. A real-time PCR detecting both HSV-1 and HSV-2 was used to quantify the viral load.
RESULTS: Median duration of HSV-1 shedding was 60 h and 48 h by PCR and culture, respectively. No HSV-2 DNA was detected in that study. Peak viral DNA load (123.6 copies/cell) occurred at 48 h with no virus detected beyond 96 h of onset of symptoms.
CONCLUSIONS: These viral load kinetics data could be used as surrogate markers of antiviral activity in future clinical trials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046320     DOI: 10.1016/j.jcv.2006.09.006

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  7 in total

Review 1.  Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.

Authors:  Christopher M Hull; Myron J Levin; Stephen K Tyring; Spotswood L Spruance
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

2.  Disseminated herpes simplex virus type 1 primary infection in a healthy individual.

Authors:  Guy Boivin; Brigitte Malette; Nathalie Goyette
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

3.  Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.

Authors:  Jocelyne Piret; Nathalie Goyette; Brian E Eckenroth; Emilien Drouot; Matthias Götte; Guy Boivin
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

4.  Both TRIF and IPS-1 adaptor proteins contribute to the cerebral innate immune response against herpes simplex virus 1 infection.

Authors:  Rafik Menasria; Nicolas Boivin; Manon Lebel; Jocelyne Piret; Jean Gosselin; Guy Boivin
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

5.  The recruitment of peripheral blood leukocytes to the brain is delayed in susceptible BALB/c compared to resistant C57BL/6 mice during herpes simplex virus encephalitis.

Authors:  Coraline Canivet; Olus Uyar; Chantal Rhéaume; Jocelyne Piret; Guy Boivin
Journal:  J Neurovirol       Date:  2019-02-13       Impact factor: 3.739

6.  Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease.

Authors:  Matthias N Witt; Gerald S Braun; Stephan Ihrler; Holger Schmid
Journal:  BMC Pulm Med       Date:  2009-05-18       Impact factor: 3.317

7.  Herpes simplex encephalitis in adult patients with MASP-2 deficiency.

Authors:  Stéphanie Bibert; Jocelyne Piret; Mathieu Quinodoz; Emilie Collinet; Vincent Zoete; Olivier Michielin; Rafik Menasria; Pascal Meylan; Titus Bihl; Véronique Erard; Florence Fellmann; Carlo Rivolta; Guy Boivin; Pierre-Yves Bochud
Journal:  PLoS Pathog       Date:  2019-12-23       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.